Jim Cramer's Club Drops CVS From Watchlist, Eyes Intel CEO Move
The Investing Club removed CVS from its Bullpen watchlist and highlighted Intel CEO's latest stance in its afternoon market update.
Jim Cramer's Investing Club pulled CVS Health from its closely watched Bullpen watchlist Wednesday, signaling a shift in conviction on the embattled pharmacy and health-insurance giant. The decision came as part of the club's daily Homestretch briefing, an actionable afternoon update timed to the final hour of trading each weekday.
CVS has faced mounting pressure across its core business segments, including pharmacy benefit management and insurance, raising questions among analysts and investors about the company's near-term trajectory. By removing the stock from the Bullpen — a holding area for names the club is considering adding to its portfolio — the Investing Club is stepping back from a potential buying opportunity it had previously flagged.
Read more Supertanker Freight Rates Tumble More Than 60% Off Record Highs →
Separately, the briefing drew attention to Intel, where CEO Pat Gelsinger has taken a notable public stand. While the specifics of that position were highlighted in the Homestretch update, Intel's leadership has been under intense scrutiny as the chipmaker navigates a prolonged turnaround effort in a fiercely competitive semiconductor landscape.
The Homestretch format is designed to give Investing Club members timely, decision-ready information before markets close, cutting through afternoon noise to surface the moves that matter most. Wednesday's edition underscored the club's willingness to make hard calls — dropping a name under consideration — rather than holding positions out of inertia.
Continue reading at US Top News and Analysis